Could university patents stand in the way of universal global access to a COVID-19 vaccine?
McDonagh, L.
(10 September 2020)
Could university patents stand in the way of universal global access to a COVID-19 vaccine?
LSE COVID-19 Blog.
(10 September 2020)
Could university patents stand in the way of universal global access to a COVID-19 vaccine?
LSE COVID-19 Blog.
Would it be right for publicly-funded universities to profit from their role in creating a COVID-19 vaccine? Luke McDonagh (LSE) looks at the case of the Oxford University/AstraZeneca collaboration, noting that its plans to offer non-exclusive, royalty-free licences only apply until the WHO declares the pandemic over.